ACLARION, INC(ACON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ACON ACLARION, INC

Pre-Mkt 09-10 06:40:18 EDT

2.42

-0.02

-0.82%

盘前2.41

-0.01-0.42%

04:00 EDT

High2.45	Low2.32	Vol13.08K
Open2.40	D1 Closing2.44	Amplitude5.50%
Mkt Cap6.98M	Tradable Cap6.35M	Total Shares2.88M
T/O31.75K	T/O Rate0.50%	Tradable Shares2.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ACON","market":"US","secType":"STK","nameCN":"ACLARION, INC","latestPrice":2.4201,"timestamp":1788984000000,"preClose":2.44,"halted":0,"volume":13080,"hourTrading":{"tag":"盘前","latestPrice":2.41,"preClose":2.4201,"latestTime":"04:00 EDT","volume":22,"amount":53.02,"timestamp":1789027209521,"change":-0.0101,"changeRate":-0.004173,"amplitude":0},"delay":0,"changeRate":-0.008155737704917954,"floatShares":2622300,"shares":2882400,"eps":-7.5967,"marketStatus":"Pre-Mkt","change":-0.0199,"latestTime":"09-10 06:40:18 EDT","open":2.4,"high":2.45,"low":2.3158,"amount":31747.11546,"amplitude":0.055,"askPrice":2.9,"askSize":200,"bidPrice":2.02,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.5967,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1650600000000,"exchange":"NASDAQ","adjPreClose":2.4201,"preHourTrading":{"tag":"盘前","latestPrice":2.41,"preClose":2.4201,"latestTime":"04:00 EDT","volume":22,"amount":53.02,"timestamp":1789027209521,"change":-0.0101,"changeRate":-0.004173,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.4201,"preClose":2.4201,"latestTime":"19:30 EDT","volume":24,"amount":59.7175,"timestamp":1788996604053,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.25554261693922764},"requestUrl":"/m/hq/s/ACON/tweets","defaultTab":"tweets","newsList":[{"id":"2660286160","title":"Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as Clarity Trial Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286160","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286160?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:06","pubTimestamp":1787223960,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660198286","title":"Aclarion - Anticipates Having Initial Internal Data Readout & Expected Public Disclosure of Early Interim Results in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2660198286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660198286?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:06","pubTimestamp":1787223960,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0L8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286989","title":"Aclarion Adds University of Arizona College of Medicine–Phoenix as Clarity Trial Site for Nociscan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286989?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:03","pubTimestamp":1787223787,"startTime":"0","endTime":"0","summary":"Aclarion adds University of Arizona College of Medicine–Phoenix as CLARITY trial site for NociscanAclarion added University of Arizona College of Medicine – Phoenix as a new enrolling site for its CLA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL5vhhx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4112","IE00BQXX3D17.EUR","SG9999014021.USD","SG9999014039.USD","SG9999014013.SGD","BK4167","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","LU2095319765.USD","BCDF","NDAQ","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","BK4585","LU0314104364.USD","SG9999014005.SGD","ACON","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660423822","title":"Aclarion Director Amanda M Williams Reports Purchase of 5,857 Common Shares Worth $15,989.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2660423822","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660423822?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:30","pubTimestamp":1787142637,"startTime":"0","endTime":"0","summary":"Aclarion director Amanda M Williams reports purchase of 5,857 common shares worth $15,989.61Aclarion director Amanda M Williams disclosed an open-market purchase of 5,857 common shares at USD 2.73 eac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLSvCHR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aclarion Director Amanda M Williams Reports Purchase of 5,857 Common Shares Worth $15,989.61","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660877424","title":"Aclarion CEO Brent Ness Reports Purchase of 5,234 Common Shares for $12,093.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2660877424","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660877424?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969840,"startTime":"0","endTime":"0","summary":"Aclarion CEO Brent Ness reports purchase of 5,234 common shares for $12,093.54Aclarion CEO Brent Ness bought 5,234 common shares in an open-market purchase at USD 2.31 per share.Direct holdings rose t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL78NXQP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aclarion CEO Brent Ness Reports Purchase of 5,234 Common Shares for $12,093.54","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658715629","title":"Aclarion Says USPTO Issues Notice of Allowance for Lumbar Disc MRS Scan-Prescription Patent Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2658715629","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658715629?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:02","pubTimestamp":1786532538,"startTime":"0","endTime":"0","summary":"Aclarion says USPTO issues notice of allowance for lumbar disc MRS scan-prescription patent applicationAclarion received a USPTO Notice of Allowance for a U.S. patent application covering “Multi-Voxel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL30bpSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BKPKM429.USD","BK4167","SG9999014013.SGD","BCDF","BK4112","IE00BN0W2V16.EUR","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","ACON","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634137","title":"Aclarion Q2 FY26 Net Loss Narrows 59.27% to $2.75 Million; Revenue Rises 30.5% to $25,208","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634137","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634137?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:01","pubTimestamp":1786021309,"startTime":"0","endTime":"0","summary":"Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208Aclarion posted a net loss of $2.75 million for the quarter ended June 30, 2026, widening from the year-earlier","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL822ZnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655628518","title":"Aclarion Announces Availability of CEO Shareholder Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2655628518","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655628518?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:18","pubTimestamp":1785323907,"startTime":"0","endTime":"0","summary":"Aclarion announces availability of CEO shareholder letterAclarion announced the availability of a CEO shareholder letter covering the first half of 2026: CEO Shareholder Letter.Letter cited 141% year-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL8hCx2l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271547","title":"Aclarion Notifies Availability of Press Release on Nociscan Clinical Use Abstracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653271547?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:00","pubTimestamp":1784631621,"startTime":"0","endTime":"0","summary":"Aclarion Notifies Availability of Press Release on Nociscan Clinical Use AbstractsAclarion posted a new press release on July 21, 2026 on Nociscan real-world use presented at the ASPN annual meeting.E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL4mJHSw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","LU2210150020.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4167","BK4585","BCDF","BK4588","LU2095319765.USD","SG9999014021.USD","SG9999014005.SGD","IE00BN0W2W23.USD","ACON","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467360","title":"Aclarion Launches Market Access Program With PRIA Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467360","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467360?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:02","pubTimestamp":1781006542,"startTime":"0","endTime":"0","summary":"Aclarion (ACON) has launched a market access program in partnership with PRIA Healthcare.Financial terms were not disclosed.The initiative is part of an effort to advance Nociscan, Aclarion's propriet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","BK4167","LABU","BK4137","BK4585","HCSG","XBI","LU0029874061.USD","XLV","BK4581","ACONW","BK4588","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486460","title":"BRIEF-Aclarion Stockholders Approve All Proposals At 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486460?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916754,"startTime":"0","endTime":"0","summary":"BRIEF-Aclarion Stockholders Approve All Proposals At 2026 Annual MeetingJune 8 (Reuters) - Aclarion Inc ACON.O:ACLARION STOCKHOLDERS APPROVE ALL PROPOSALS AT 2026 ANNUAL MEETINGSource text: ID:nGNXb1xZyDFurther company coverage: ACON.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA1CHMSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","ACONW","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486177","title":"Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486177?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA8WSNGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACONW","ACON","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641457486","title":"Aclarion - Board Says Echo Lake Proposal Significantly Undervalues Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2641457486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641457486?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA8WSNGG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACON","BK4167","ACONW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641494486","title":"Press Release: Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641494486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641494486?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":"BROOMFIELD, Colo., June 08, 2026  -- Aclarion, Inc.,  , a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence  algorithms to help physicians identify the location of chronic low back pain, today issued the following statement in response to a recent communication issued by Echo Lake Capital and its principal, Ephraim Fields.Aclarion's Board of Directors carefully reviewed Echo Lake's unsolicited public proposal and unanimously determined to reject it. The Board believes that the proposal significantly undervalues the Company and its strategic potential. The Board further determined that the proposal does not appropriately reflect the range of opportunities it believes are available to create value for all shareholders.The Board also determined that the structure of the proposal would disproportionately benefit Echo Lake at the expense of other shareholders. Echo Lake's proposal to acquire the Company at $4.00 per share wou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641866184","title":"Press Release: Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641866184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641866184?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916400,"startTime":"0","endTime":"0","summary":"BROOMFIELD, Colo., June 08, 2026  -- Aclarion, Inc.,  , a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence  algorithms to help physicians identify the location of chronic low back pain, today announced that its stockholders approved all proposals at its 2026 Annual Meeting of Stockholders held on June 4, 2026.The approved proposals included the election of Jeffrey Thramann, Brent Ness, Stephen Deitsch, Scott Breidbart, David Neal, William Wesemann, and Amanda Williams to the Board of Directors to serve until the 2027 annual meeting, the ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm, and the approval of an amendment to the Company's 2022 equity incentive plan.This press release contains information that may constitute forward-looking statements, including with respect to Aclarion's Board of Directors, Aclarion's business strategy, and other matters. For","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641816794","title":"Aclarion holds annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641816794","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641816794?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:50","pubTimestamp":1780606225,"startTime":"0","endTime":"0","summary":"Aclarion held its annual shareholder meeting on June 4, 2026.Shareholders backed the slate of seven director nominees, confirming their election.Appointment of independent auditor Haynie & Company was ratified.An amendment to the 2022 equity incentive plan was adopted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL8gzVC9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640190351","title":"Aclarion signs agreement with Institute of Neuro Innovation to offer Nociscan in Los Angeles area","url":"https://stock-news.laohu8.com/highlight/detail?id=2640190351","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640190351?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:01","pubTimestamp":1780480888,"startTime":"0","endTime":"0","summary":"Aclarion signed an agreement with Los Angeles-based Institute of Neuro Innovation to add its Nociscan platform at the clinic.Partnership expands Nociscan availability in the greater Los Angeles area, supporting the company’s commercial rollout strategy.Institute plans a real-world evidence study comparing Nociscan disc biomarker data with SPECT-CT bone metabolic findings in chronic low back pain.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9FlvBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","BK4588","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014005.SGD","ACON","SG9999014013.SGD","IE00BGHQF748.EUR","BK4167","LU0314104364.USD","LU2210149790.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640655958","title":"Aclarion says Nociscan study links intradiscal propionic acid to immune-activated back pain subtype","url":"https://stock-news.laohu8.com/highlight/detail?id=2640655958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640655958?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:02","pubTimestamp":1780308135,"startTime":"0","endTime":"0","summary":"Aclarion highlighted new NIH-funded research using its Nociscan MRS platform in Modic type 1 back-pain patients; results have already been presented.The study linked a disc-derived biochemical signal to a distinct immune-activation subtype, supporting a non-structural driver of pain in some patients.The findings broaden Nociscan’s strategic positioning beyond surgical decision support into patient stratification for inflammation, infection-related processes, or immune-associated pain.This could expand the addressable market by guiding future personalized therapy development, including anti-inflammatory, antimicrobial, or immune-modulating approaches.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbM5rSj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","ACON","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4167","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","SG9999014021.USD","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","SG9999014039.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639621155","title":"Aclarion Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2639621155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639621155?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:53","pubTimestamp":1780051980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 29, 2026 06:53 ET (10:53 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639613679","title":"Aclarion to ‘carefully review and evaluate’ Echo Lake’s proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2639613679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639613679?lang=en_us&edition=fundamental","pubTime":"2026-05-29 02:55","pubTimestamp":1779994511,"startTime":"0","endTime":"0","summary":"Aclarion (ACON) issued the following statement in response to the press release issued by Echo Lake Capital and its offer to acquire the company fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aclarion-to-carefully-review-and-evaluate-echo-lakes-proposal-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aclarion-to-carefully-review-and-evaluate-echo-lakes-proposal-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aclarion.com","stockEarnings":[{"period":"1week","weight":0.0477},{"period":"1month","weight":0.0255},{"period":"3month","weight":-0.2461},{"period":"6month","weight":-0.2732},{"period":"1year","weight":-0.6591},{"period":"ytd","weight":-0.4739}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.316115},{"month":2,"riseRate":0.25,"avgChangeRate":-0.352706},{"month":3,"riseRate":0.25,"avgChangeRate":-0.242097},{"month":4,"riseRate":0.25,"avgChangeRate":-0.127028},{"month":5,"riseRate":0.4,"avgChangeRate":0.033451},{"month":6,"riseRate":0.2,"avgChangeRate":-0.116549},{"month":7,"riseRate":0.4,"avgChangeRate":-0.061018},{"month":8,"riseRate":0.6,"avgChangeRate":-0.044129},{"month":9,"riseRate":0.4,"avgChangeRate":-0.141762},{"month":10,"riseRate":1,"avgChangeRate":0.110748},{"month":11,"riseRate":0,"avgChangeRate":-0.1724},{"month":12,"riseRate":0,"avgChangeRate":-0.242895}],"exchange":"NASDAQ","name":"ACLARION, INC","nameEN":"ACLARION, INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ACLARION, INC(ACON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ACLARION, INC(ACON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ACLARION, INC,ACON,ACLARION, INC股票,ACLARION, INC股票老虎,ACLARION, INC股票老虎国际,ACLARION, INC行情,ACLARION, INC股票行情,ACLARION, INC股价,ACLARION, INC股市,ACLARION, INC股票价格,ACLARION, INC股票交易,ACLARION, INC股票购买,ACLARION, INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ACLARION, INC(ACON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ACLARION, INC(ACON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}